[{"id":"fce31002-7ca7-4a3a-bd75-6e5137c66715","acronym":"CT32","url":"https://clinicaltrials.gov/study/NCT04797702","created_at":"2021-03-15T15:53:41.080Z","updated_at":"2024-07-02T16:36:33.320Z","phase":"Phase 1/2","brief_title":"Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer.","source_id_and_acronym":"NCT04797702 - CT32","lead_sponsor":"Shanghai Junshi Bioscience Co., Ltd.","biomarkers":" EGFR • PD-L1 • ALK • ROS1","pipe":" | ","alterations":" PD-L1 expression • ALK rearrangement • EGFR wild-type • ROS1 rearrangement","tags":["EGFR • PD-L1 • ALK • ROS1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • ALK rearrangement • EGFR wild-type • ROS1 rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Loqtorzi (toripalimab-tpzi) • Haiyitan (gumarontinib)"],"overall_status":"Recruiting","enrollment":" Enrollment 67","initiation":"Initiation: 04/15/2021","start_date":" 04/15/2021","primary_txt":" Primary completion: 07/31/2023","primary_completion_date":" 07/31/2023","study_txt":" Completion: 02/26/2024","study_completion_date":" 02/26/2024","last_update_posted":"2021-03-15"},{"id":"3221b2ed-59d5-42f8-9362-f16e8b9e7f5e","acronym":"","url":"https://clinicaltrials.gov/study/NCT03466268","created_at":"2021-01-17T17:53:18.793Z","updated_at":"2024-07-02T16:36:48.917Z","phase":"Phase 1","brief_title":"Study to Evaluate the Safety and Anti-tumor Activity of SCC244","source_id_and_acronym":"NCT03466268","lead_sponsor":"Haihe Biopharma Co., Ltd.","biomarkers":" KRAS • ALK • MET • ROS1","pipe":" | ","alterations":" EGFR mutation • MET amplification • MET exon 14 mutation • MET overexpression • ALK mutation • MET mutation • ROS1 wild-type","tags":["KRAS • ALK • MET • ROS1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • MET amplification • MET exon 14 mutation • MET overexpression • ALK mutation • MET mutation • ROS1 wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Haiyitan (gumarontinib)"],"overall_status":"Unknown status","enrollment":" Enrollment 113","initiation":"Initiation: 09/14/2017","start_date":" 09/14/2017","primary_txt":" Primary completion: 10/01/2021","primary_completion_date":" 10/01/2021","study_txt":" Completion: 10/01/2021","study_completion_date":" 10/01/2021","last_update_posted":"2020-03-11"}]